A Tale of Two Scores: Comparing Coronary Artery Calcium and Polygenic Risk Scores for the Prediction of Coronary Heart Disease Events
Clinical Chemistry · 07.02.2024 · 70 (2) · 358-360
DOI: 10.1093/clinchem/hvad150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Chemistry, online erschienen am 19.10.2023. Verfasst von Nicholas A Marston und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Harvard Medical School, Boston, MA, United States. Hauptthemen laut MEDLINE: Calcium, Coronary Artery Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Polygenic risk scores (PRS), also called genetic risk scores or polygenic scores, have recently garnered attention as potential clinical tools for risk prediction and precision medicine. A PRS for a given quantitative trait (e.g., fasting blood glucose) or disease (e.g., type 2 diabetes) is a weighted sum of effect sizes from hundreds to millions of genetic positions across the genome, derived using data from large genome-wide association studies. A PRS thus provides a quantitative measure of an individual’s genetic predisposition to the trait or disease, relative to the overall population. For some diseases, such as coronary artery disease (CAD) and breast cancer, a PRS value in the upper tail of the population distribution can indicate equivalent risk to monogenic forms of the disease (e.g., familial hypercholesterolemia and hereditary breast and ovarian cancer) (1). Because genotype is fixed at birth, PRS have particular appeal for preventive medicine, identifying high-risk individuals earlier in the lifecourse and enabling earlier or more intensive screening or preventive interventions than those recommended for the general population. While PRS have limitations, including reduced validity in populations different from those in which they were developed, PRS assays with interpreted clinical reports are increasingly available as direct-to-consumer or laboratory-developed tests, and several large programs and research studies are actively evaluating their clinical implementation. In this perspective piece, we summarize the current state of CAD PRS (PRSCAD) clinical application in preventive cardiology, highlighting a recent comparison to coronary artery calcium (CAC) scoring by Khan and colleagues in the Journal of the American Medical Association (2).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Harvard Medical School, Boston, MA, United States.
- Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
- VA Boston Healthcare System, Boston, MA, United States.
- Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.
ORCID-Profile: Jason L Vassy
Förderung
- NHLBI NIH HHS
- NHGRI NIH HHS
Zitieren
APA
Marston, N. A., & Vassy, J. L. (2024). A Tale of Two Scores: Comparing Coronary Artery Calcium and Polygenic Risk Scores for the Prediction of Coronary Heart Disease Events. Clinical Chemistry, 70(2), 358-360. https://doi.org/10.1093/clinchem/hvad150
Vancouver
Marston NA, Vassy JL. A Tale of Two Scores: Comparing Coronary Artery Calcium and Polygenic Risk Scores for the Prediction of Coronary Heart Disease Events. Clinical Chemistry. 2024;70(2):358-360. doi:10.1093/clinchem/hvad150
BibTeX
@article{Marston2024,
author = {Marston, Nicholas A and Vassy, Jason L},
title = {A Tale of Two Scores: Comparing Coronary Artery Calcium and Polygenic Risk Scores for the Prediction of Coronary Heart Disease Events},
journal = {Clinical Chemistry},
year = {2024},
volume = {70},
number = {2},
pages = {358--360},
doi = {10.1093/clinchem/hvad150}
}
EUVIMED